A Behavior‐Integrated Potency Assay for Quantitative Evaluation of Extracellular Matrix Remodeling by Mesenchymal Stem/Stromal Cells
Biotechnology and Bioengineering · 2026
DOI: 10.1002/bit.70298 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, 2026. Verfasst von Shao Ying Tan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Graduate School of Engineering, The University of Osaka, Suita, Japan. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Extracellular Matrix. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Reliable potency assays are critical for ensuring the therapeutic consistency and manufacturing quality of mesenchymal stem/stromal cells (MSCs). Conventional assays based on soluble factor quantification often fail to capture extracellular matrix (ECM) remodeling capacity and exhibit high variability. We developed a biologically relevant, image‐based potency assay that directly quantifies MSCs‐mediated ECM remodeling under defined biophysical conditions. A collagen‐coated (CL) surface that provides a stable, proliferation‐suppressive microenvironment, enabling single‐cell quantification of remodeling activity using collagen hybridizing peptide staining. The ECM remodeling index ( I CHP+ ) defined an optimal working range (3.0 × 10 3 ≤ cells/cm 2 ≤ 4.5 × 10 3 ), where spatially separated MSCs achieved high analytical precision (CV < 10%). The CL‐based assay demonstrated robust repeatability across MSCs sources and biologically relevant quantitation limits. Integration of I CHP+ with γH2AX, enabled simultaneous assessment of functional potency and cell health. Response surface methodology modeling of culture duration, seeding density, and passage number revealed a dome‐shaped relationship, with maximal remodeling at early passages ( N p 1– N p 3) and 3–5 days of culture, whereas extended culture (> 6 days) decreased potency alongside elevated γH2AX expression. The model exhibited strong predictive performance (R 2 > 0.95), supporting its utility for process optimization. Collectively, this mechanism‐based potency assay enables standardized platform for potency evaluation and manufacturing control for consistent, high‐quality MSCs therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, Graduate School of Engineering, The University of Osaka, Suita, Japan.
- Research Base for Cell Manufacturability, The University of Osaka, Suita, Japan.
ORCID-Profile: Shao Ying Tan
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Tan, S. Y., Kim, M. H., & Kino-Oka, M. (2026). A Behavior‐Integrated Potency Assay for Quantitative Evaluation of Extracellular Matrix Remodeling by Mesenchymal Stem/Stromal Cells. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70298
Vancouver
Tan SY, Kim MH, Kino-Oka M. A Behavior‐Integrated Potency Assay for Quantitative Evaluation of Extracellular Matrix Remodeling by Mesenchymal Stem/Stromal Cells. Biotechnology and Bioengineering. 2026. doi:10.1002/bit.70298
BibTeX
@article{Tan2026,
author = {Tan, Shao Ying and Kim, Mee-Hae and Kino-Oka, Masahiro},
title = {A Behavior‐Integrated Potency Assay for Quantitative Evaluation of Extracellular Matrix Remodeling by Mesenchymal Stem/Stromal Cells},
journal = {Biotechnology and Bioengineering},
year = {2026},
doi = {10.1002/bit.70298}
}
EUVIMED